Related Experiment Video
Updated: Jan 20, 2026
Assaying Proteasomal Degradation in a Cell-free System in Plants
Published on: March 26, 2014
Schiff base Cu(II) complexes as inhibitors of proteasome in human cancer cells
Background:
It has been demonstrated that proteasome inhibitors might be potential anticancer drugs. The copper complexes can be used as specific proteasome inhibitors in tumor cells able to induce apoptosis by the ubiquitin-proteasome pathway. The goal of our study was to test the cytotoxic and proteasome inhibitory effects of five Schiff base Cu(II) complexes - [Cu2(sal-D,L-glu)2(isoquinoline)2] . 2C2H5OH (1), [Cu(sal-5-met-L-glu)(H2O)].H2O (2), [Cu(ethanol)2(imidazole)4][Cu2(sal-D,L-glu)2(imidazole)2] (3), [Cu(sal-D,L-glu)(2-methylimidazole)] (4) on human lung carcinoma cells A549, cervix carcinoma cells HeLa and glioblastoma cells U-118MG.
Material And Methods:
For the cytotoxic analysis we used MTT test and for monitoring the proteasome inhibition western blot analysis.
Results:
We have observed different cytotoxic effects of tested complexes on human cancer cells depending on the ligand present in their structure. Cu(II) complexes 4 and 5 were the most effective against A549 cells; all complexes were cytotoxic against HeLa cells and the complex 4 was the most effective against U-118MG. Moreover, we have detected the inhibition of the proteasome activity in human cancer cells A549 by Cu(II) complexes 1, 2 and 4 at IC50 concentration.
Conclusion:
Results of our study suggest that isoquinoline- and imidazole-based copper complexes could be used as inhibitors of the proteasome system in cancer cells A549 (Tab. 1, Fig. 1, Ref. 26).
Insights
Copper complexes show potential as anticancer drugs by inhibiting proteasome activity. Schiff base Cu(II) complexes demonstrated significant cytotoxic effects and proteasome inhibition in various human cancer cells.
Area of Science:
- Biochemistry
- Cancer Research
- Medicinal Chemistry
Background:
- Proteasome inhibitors are investigated as anticancer agents.
- Copper complexes can target the ubiquitin-proteasome pathway in tumor cells.
- Schiff base Cu(II) complexes are explored for their therapeutic potential.
Purpose of the Study:
- To evaluate the cytotoxic and proteasome inhibitory effects of five Schiff base Cu(II) complexes.
- To assess the efficacy of these complexes against human lung carcinoma (A549), cervix carcinoma (HeLa), and glioblastoma (U-118MG) cells.
Main Methods:
- Cytotoxicity was determined using the MTT assay.
- Proteasome inhibition was monitored via western blot analysis.
Main Results:
- Complexes exhibited varying cytotoxic effects across different cancer cell lines.
- Cu(II) complexes 4 and 5 were most effective against A549 cells.
- Complex 4 showed the highest efficacy against U-118MG cells, and all complexes were cytotoxic to HeLa cells.
- Cu(II) complexes 1, 2, and 4 inhibited proteasome activity in A549 cells at IC50 concentration.
Conclusions:
- Isoquinoline- and imidazole-based copper complexes show promise as proteasome inhibitors in cancer therapy.
- These findings support the potential use of specific copper complexes in targeting cancer cells via the proteasome pathway.
More Related Videos
Related Concept Videos
02:18The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
04:12Protein Aggregate Formation Assay: A Method to Detect and Quantify Protein Aggregation in Cultured Cells upon Induction by Proteasome Inhibitor
07:43Assaying Proteasomal Degradation in a Cell-free System in Plants
09:51Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
10:25Monitoring of Ubiquitin-proteasome Activity in Living Cells Using a Degron (dgn)-destabilized Green Fluorescent Protein (GFP)-based Reporter Protein
06:44Hydrolysis of a Ni-Schiff-Base Complex Using Conditions Suitable for Retention of Acid-labile Protecting Groups